Website
VCID: 79892
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Developer of proteolytically-activated antibodiesFunding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Roche Venture Fund | The corporate venture fund of the healthcare company Roche | Switzerland |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies |
+1 (203) 855-0400 |
N/A |
|
|
Roche Venture Fund The corporate venture fund of the healthcare company Roche |
Series B |